Breaking News, Collaborations & Alliances

DelSiTech and Tolmar International Sign Global License & Development Agreement

Aim to develop novel products for the benefit of patients in need of improved therapies.

Author Image

By: Charlie Sternberg

Associate Editor

Clinical-stage drug delivery and development company, DelSiTech Ltd., and Tolmar International Ltd., a fully-integrated pharmaceutical company, have signed a global license and development agreement, further strengthening their collaboration, following investment from Tolmar in January 2024. Terms of the Agreement Under the terms of the agreement, Tolmar will obtain a global license to utilize DelSiTech’s proprietary, silica-based, drug delivery technology platform for the development...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters